Cardiff Oncology

$11.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.46 (-3.97%) Today

+$0.66 (+5.92%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CRDF and other stocks, options, and ETFs commission-free!

About CRDF

Cardiff Oncology, Inc. Common Stock, also called Cardiff Oncology, is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in 1999 and is headquartered in San Diego, CA. The listed name for CRDF is Cardiff Oncology, Inc. Common Stock.

CEO

Mark Erlander

Employees

Headquarters

San Diego, California

Founded

1999

Market Cap

393.52M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.43M

High Today

$11.92

Low Today

$10.21

Open Price

$11.77

Volume

7.09M

52 Week High

$25.50

52 Week Low

$0.701

Collections

CRDF Earnings

-$0.79

-$0.53

-$0.26

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 25, After Hours